Lack of REDD1 reduces whole body glucose and insulin tolerance, and impairs skeletal muscle insulin signaling

scientific article published on 14 October 2014

Lack of REDD1 reduces whole body glucose and insulin tolerance, and impairs skeletal muscle insulin signaling is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BBRC.2014.10.032
P698PubMed publication ID25445588
P5875ResearchGate publication ID266914143

P50authorDavid C. WrightQ89459465
P2093author name stringDavid L Williamson
Cory M Dungan
P433issue4
P304page(s)778-783
P577publication date2014-10-14
P1433published inBiochemical and Biophysical Research CommunicationsQ864228
P1476titleLack of REDD1 reduces whole body glucose and insulin tolerance, and impairs skeletal muscle insulin signaling
P478volume453

Reverse relations

cites work (P2860)
Q36339315Aberrant REDD1-mTORC1 responses to insulin in skeletal muscle from Type 2 diabetics
Q36987209Acute Alcohol-Induced Decrease in Muscle Protein Synthesis in Female Mice Is REDD-1 and mTOR-Independent
Q64121088Acute treadmill exercise discriminately improves the skeletal muscle insulin-stimulated growth signaling responses in mice lacking REDD1
Q37568469Caloric Restriction Normalizes Obesity-Induced Alterations on Regulators of Skeletal Muscle Growth Signaling
Q36751821Disruption of REDD1 gene ameliorates sepsis-induced decrease in mTORC1 signaling but has divergent effects on proteolytic signaling in skeletal muscle
Q37139408Emerging role for regulated in development and DNA damage 1 (REDD1) in the regulation of skeletal muscle metabolism
Q45857542Hypoxia-induced regulation of placental REDD1 and mTOR was impaired in a rat model of estrogen-induced cholestasis
Q41203952Implication of REDD1 in the activation of inflammatory pathways
Q28075486Is REDD1 a Metabolic Éminence Grise?
Q51089710Regulated in Development and DNA Damage Response 1 Deficiency Impairs Autophagy and Mitochondrial Biogenesis in Articular Cartilage and Increases the Severity of Experimental Osteoarthritis
Q38762707Validation of a commercially available anti-REDD1 antibody using RNA interference and REDD1-/- mouse embryonic fibroblasts

Search more.